MTVA
MetaVia Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.69M
P/E Ratio
—
EPS
$-7.35
Beta
0.34
52W High
$19.03
52W Low
$1.17
50-Day MA
$1.46
200-Day MA
$6.29
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About MetaVia Inc.
MetaVia Inc. is a forward-thinking technology company specializing in advanced digital solutions that drive connectivity and productivity across multiple sectors. Utilizing state-of-the-art artificial intelligence and cloud computing, MetaVia provides scalable platforms that cater to the unique requirements of its varied clientele. The company's dedication to sustainability and social responsibility not only meets evolving market expectations but also positions it for significant growth. With a strategic focus on adaptability and collaboration, MetaVia is well-positioned to capitalize on opportunities in the fast-evolving technology landscape, aiming to deliver substantial value to shareholders.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-13.69M |
| Operating Margin | 0.00% |
| Return on Equity | -195.60% |
| Return on Assets | -62.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.31 |
| Price-to-Book | 1.45 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $5.16M |
| Float | $3.34M |
| % Insiders | 34.50% |
| % Institutions | 2.94% |
Historical Volatility
HV 10-Day
76.27%
HV 20-Day
87.58%
HV 30-Day
85.98%
HV 60-Day
82.86%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($19.33 target)
1
Strong Buy2
BuyData last updated: 4/30/2026